Balyasny Asset Management LLC Amryt Pharma PLC Transaction History
Balyasny Asset Management LLC
- $54.9 Billion
- Q2 2024
A detailed history of Balyasny Asset Management LLC transactions in Amryt Pharma PLC stock. As of the latest transaction made, Balyasny Asset Management LLC holds 4,980,300 shares of AMYT stock, worth $0. This represents 0.19% of its overall portfolio holdings.
Number of Shares
4,980,300Holding current value
$0% of portfolio
0.19%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AMYT
# of Institutions
5Shares Held
142KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY130KShares$01.5% of portfolio
-
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L210.2KShares$00.01% of portfolio
-
Brewin Dolphin LTD London, X01.12KShares$00.0% of portfolio
-
Burleson & Company, LLC22Shares$00.0% of portfolio
-
Global Frontier Investments LLC Charleston, SC0Shares$00.0% of portfolio
About Amryt Pharma plc
- Ticker AMYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 64,177,000
- Description
- Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...